Trial intelligence / Profile preview

APRF for Pain Prevention After Mandibular Third Molar Removal

NCT06377839Phase 1Recruiting

Sponsor
Aalborg University Hospital
Start
Jan 2024
Primary completion
Apr 2024
Modality
Cell Therapies
Countries
1
01

Overview

Phase 1, randomised, open-label trial of advanced platelet-rich fibrin in postoperative pain (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Assessment of postoperative pain by using Visual Analogue Scale at 15 days. Started Jan 2024; status: recruiting.

02

Drugs

advanced platelet-rich fibrin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06377839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06377839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call